Related Experiment Video
Updated: Oct 17, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Necroptosis and tumor progression.
Jiong Yan1, Peixing Wan1, Swati Choksi1
1Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Necroptosis, a programmed cell death, defends against pathogens and inflammation. Targeting necroptosis shows promise for novel cancer therapies by impacting tumor growth and spread.
Area of Science:
- Cellular Biology
- Immunology
- Oncology
Background:
- Necroptosis is a crucial host defense mechanism against pathogens.
- Dysregulated necroptosis contributes to inflammatory diseases.
- Emerging evidence links necroptosis to cancer development and metastasis.
Purpose of the Study:
- To review the role of necroptosis in tumorigenesis and metastasis.
- To discuss the regulation and function of tumor cell necroptosis.
- To highlight necroptosis as a potential cancer therapeutic target.
Main Methods:
- Literature review of recent studies on necroptosis.
- Analysis of necroptosis regulation in tumor cells.
- Discussion of necroptosis's impact on cancer progression.
Main Results:
- Necroptosis plays a dual role in host defense and disease.
- Tumor cell necroptosis influences tumorigenesis and metastasis.
- Targeting necroptosis pathways offers therapeutic potential in oncology.
Conclusions:
- Understanding necroptosis regulation in tumors is critical.
- Necroptosis modulation presents a promising avenue for cancer treatment.
- Further research into necroptosis functions in cancer is warranted.
More Related Videos
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
09:43Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...